310 related articles for article (PubMed ID: 28825114)
1. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Su SH; Wu YF; Lin Q; Hai J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.
Su SH; Wu YF; Lin Q; Yu F; Hai J
Neuroscience; 2015 Aug; 301():563-75. PubMed ID: 25795598
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
[TBL] [Abstract][Full Text] [Related]
4. URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion.
Su SH; Wu YF; Lin Q; Wang DP; Hai J
J Neuroinflammation; 2019 Dec; 16(1):260. PubMed ID: 31815636
[TBL] [Abstract][Full Text] [Related]
5. The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling.
Wang DP; Lv QL; Lin Q; Kang K; Jin KY; Hai J
Neurotox Res; 2020 Apr; 37(4):847-856. PubMed ID: 31808139
[TBL] [Abstract][Full Text] [Related]
6. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
7. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
Hasanein P; Teimuri Far M
Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
[TBL] [Abstract][Full Text] [Related]
8. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
9. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
10. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
Wang DP; Yin H; Kang K; Lin Q; Su SH; Hai J
Psychiatry Res; 2018 Sep; 267():281-288. PubMed ID: 29945070
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
12. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
Aguirre-Rueda D; Guerra-Ojeda S; Aldasoro M; Iradi A; Obrador E; Mauricio MD; Vila JM; Marchio P; Valles SL
PLoS One; 2015; 10(4):e0122843. PubMed ID: 25874692
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats.
Huo J; Ma R; Chai X; Liang HJ; Jiang P; Zhu XL; Chen X; Su BX
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):494-503.e1. PubMed ID: 30195603
[TBL] [Abstract][Full Text] [Related]
14. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
15. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
17. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
18. URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy.
Wang D; Lin Q; Su S; Liu K; Wu Y; Hai J
Neuroscience; 2017 Mar; 344():293-304. PubMed ID: 28042028
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.
Burstein O; Shoshan N; Doron R; Akirav I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):129-139. PubMed ID: 29458190
[TBL] [Abstract][Full Text] [Related]
20. Tetrachlorobenzoquinone exhibits neurotoxicity by inducing inflammatory responses through ROS-mediated IKK/IκB/NF-κB signaling.
Fu J; Shi Q; Song X; Xia X; Su C; Liu Z; Song E; Song Y
Environ Toxicol Pharmacol; 2016 Jan; 41():241-50. PubMed ID: 26745386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]